ClinicalTrials.gov
public full text
Public Domain
Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC#125858
- Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer#1171050
- TheraSphere With Durvalumab and Tremelimumab for HCC#407726
- A Study of Anlotinib in Patients With Hepatocellular Carcinoma#837610
- A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC#968392
Record · ID 245526
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive